This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Martin Johnson
Scientist at Eli Lilly
Speaker

Profile

Martin D. Johnson works for Eli Lilly and Company in Synthetic Molecule Design and Development. He received his dual doctorate in chemical engineering and environmental engineering from the University of Michigan in 2000. Dr. Johnson was awarded the 2016 ACS Award for Affordable Green Chemistry for work with continuous aerobic oxidations, the 2016 AIChE Award for Outstanding Contribution to QbD for Drug Substance for implementation of continuous processes, and the 2021 AIChE CRE Practice Award for design and implementation of continuous reactors in the pharmaceutical industry. Recently his group has been applying chemical engineering concepts to improve oligonucleotide syntheses.